Status:
RECRUITING
Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
University Medical Center Groningen
Radboud University Medical Center
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Almost 90% of systemic sclerosis (SSc) patients experience hand function limitation, which leads to impaired daily functioning and work participation. An important cause of impaired hand function are ...
Eligibility Criteria
Inclusion
- Age \> 18 years
Exclusion
- Patients with diabetic cheiroarthropathy and Dupuytren's disease, based on expert opinion
Key Trial Info
Start Date :
April 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06133244
Start Date
April 19 2024
End Date
April 1 2028
Last Update
May 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Utrecht
Utrecht, Netherlands